Metraipolis › archive › dc_5ce78e2e7e5b
Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41155373
- DOI
- 10.3390/ijms262010082
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:58:50.784Z
- SHA-256 of the archived text
38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4- Stable URL of this page
https://metraipolis.com/documento/dc_5ce78e2e7e5b
How to cite
Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373 — Europe PMC (en), https://europepmc.org/article/MED/41155373 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ce78e2e7e5b (Metraipolis archive dc_5ce78e2e7e5b, sha256 38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4)
BibTeX
@misc{dc5ce78e2e7e5b,
title = {Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41155373},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ce78e2e7e5b; sha256 38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155373. Agents can read the archived copy with the MCP tool read_document.